These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


405 related items for PubMed ID: 15471827

  • 21. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 26. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
    Nakamoto Y, Sakamoto S, Okada T, Senda M, Higashi T, Saga T, Togashi K.
    AJR Am J Roentgenol; 2007 Jan; 188(1):257-67. PubMed ID: 17179375
    [Abstract] [Full Text] [Related]

  • 27. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL.
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of 18F-FDG PET in assessment of response in non-small cell lung cancer.
    Hicks RJ.
    J Nucl Med; 2009 May; 50 Suppl 1():31S-42S. PubMed ID: 19380411
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data.
    Gregory DL, Hicks RJ, Hogg A, Binns DS, Shum PL, Milner A, Link E, Ball DL, Mac Manus MP.
    J Nucl Med; 2012 Jul; 53(7):1007-15. PubMed ID: 22677701
    [Abstract] [Full Text] [Related]

  • 37. FDG-PET/CT in the diagnosis of recurrent breast cancer.
    Murakami R, Kumita S, Yoshida T, Ishihara K, Kiriyama T, Hakozaki K, Yanagihara K, Iida S, Tsuchiya S.
    Acta Radiol; 2012 Feb 01; 53(1):12-6. PubMed ID: 22067206
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clarifying the diagnosis of clinically suspected recurrence of cervical cancer: impact of 18F-FDG PET.
    van der Veldt AA, Buist MR, van Baal MW, Comans EF, Hoekstra OS, Molthoff CF.
    J Nucl Med; 2008 Dec 01; 49(12):1936-43. PubMed ID: 18997039
    [Abstract] [Full Text] [Related]

  • 40. PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer.
    Shyn PB, Madan R, Wu C, Erturk SM, Silverman SG.
    AJR Am J Roentgenol; 2010 Feb 01; 194(2):414-21. PubMed ID: 20093604
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.